Search filters

List of works by Paolo Milani

A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis

scientific article published on 18 May 2015

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

scientific article

A patient with AL amyloidosis with negative free light chain results.

scientific article published in June 2016

A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis.

scientific article published on 27 January 2017

A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis.

scientific article published on 14 September 2012

A practical approach to the diagnosis of systemic amyloidoses.

scientific article published on 30 January 2015

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

article

An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis

scientific article published on 30 September 2019

Attitudes about when and how to treat patients with AL amyloidosis: an international survey.

scientific article published on 31 August 2017

Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure

scientific article published on 3 March 2012

Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis

scientific article published on 26 March 2020

Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays

scientific article published on 27 March 2017

Conventional Therapy for Amyloid Light-Chain Amyloidosis

scientific article published on 30 April 2020

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

scientific article published on 4 July 2017

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

scientific article published on 27 December 2016

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis

scientific article published on 31 January 2018

Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis

scientific article published in 2024

High rate of profound clonal and renal responses with Daratumumab treatment in heavily pre-treated patients with AL amyloidosis and high bone marrow plasma cell infiltrate

scientific article published on 13 April 2020

Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis.

scientific article published in March 2017

Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients

scientific article published on 01 June 2011

MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms

scientific article published on 21 September 2018

Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment.

scientific article published on 26 September 2013

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients

scientific article published on 25 July 2014

Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis

scientific article published on 09 November 2011

Monoclonal IgM-related AL amyloidosis

scientific article published on June 2016

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

New concepts in the treatment and diagnosis of amyloidosis

scientific article published on 8 January 2018

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

scientific article published on 22 April 2016

Novel strategies for the diagnosis and treatment of cardiac amyloidosis.

scientific article

Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis.

scientific article published on 11 May 2015

Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis.

scientific article published on 9 August 2011

Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach.

scientific article

Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome.

scientific article

Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome.

scientific article published on 25 May 2017

Patterns of relapse after upfront bortezomib therapy in AL amyloidosis

scientific article published on 01 March 2017

Presentation and outcome with second line treatment in AL amyloidosis previously sensitive to non-transplant therapies.

scientific article published on 3 November 2017

Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis

scientific article published on 01 May 2014

Prognostication of survival and progression to dialysis in AA amyloidosis

scientific article published on 01 March 2017

Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells

scientific article

Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

article

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide

scientific article published on 30 April 2011

Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions

scientific article

Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response

scientific article published on 01 March 2017

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients

scientific article published on 06 June 2019

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity.

scientific article

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

scientific article published on 19 July 2010

The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis

scientific article published on 01 June 2016

The lung in amyloidosis.

scientific article published on 6 September 2017

The next generation of novel therapies for the management of relapsed multiple myeloma

scientific article

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

scientific article published on 14 August 2018

Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasone.

scientific article published in February 2011

Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis

scientific article published on 01 March 2017

Paulina is supported by:

About Paulina

Help